This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Agriculture Improvement Act of 2018 (“ 2018 Farm Bill ”) legalized hemp by removing the crop and its derivatives from the definition of marijuana under the Controlled Substances Act (“CSA”) and by providing a detailed framework for the cultivation of hemp. Today we turn to North Carolina. producers and consumers.'”
The hemp industry is up in arms over the USDA’s interim rules establishing a domestic hemp program. Most of us in the hemp industry are well-aware of the major issues in the interim rules: 15-day pre-harvest testing requirements, total THC, DEA laboratories, and crop insurance to name a few. 3% Total THC. 3% Total THC.
The Food and Drug Administration (FDA) may soon change its tune on hemp-derived CBD (Hemp CBD) thanks to a bill recently filed by chairman of the House Agriculture Committee, Rep. The FDA’s view is that Hemp CBD was not marketed as such prior to the investigation of CBD as a drug. Collin Peterson (D-MN) and cosponsored by Reps.
The HIA issued a statement in support of delta 8 THC and other hempcannabinoids. The Hemp Industries Association (HIA) issued a press release and accompanying legal position statement in support of delta-8 THC and other hempcannabinoids today. ATTORNEY ROD KIGHT REPRESENTS HEMP BUSINESSES THROUGHOUT THE WORLD.
Drug Enforcement Administration (“DEA”) published an interim final rule surrounding hemp and hemp derivatives. Although the 2018 Farm Bill legalized hemp and hemp derivatives under.3% 9 -THC, hemp processing has always fallen in a regulatory “grey-zone” because of the lack of regulations. percent ?
It is a synthetic cannabinoid that produces psychedelic effects to its users. THC-O is not an entirely natural cannabinoid. It’s one of many synthetic cannabinoids and does not occur on its own without human intervention. It is made by extracting CBD from hemp. as long as it comes from hemp. About THC-O.
The debate surrounding delta-8 THC and the proper regulation of intoxicating hemp products has accelerated greatly over the last several months, fueled by multiple court decisions, federal policy actions, and new state laws. This case provides a great deal of clarity for many seeking to enforce trademark protections for hemp products.
Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). 1 Simultaneously, the AAFP acknowledges preliminary evidence indicates marijuana and cannabinoids may have potential therapeutic benefits, while also recognizing subsequent negative public health and health outcomes associated with cannabis use.
There’s one minor cannabinoid that’s having a major moment, as of recently. Even though there are nearly 144 cannabinoids found in cannabis flower - it’s not everyday you hear about those that are considered ‘minor’. Now that more attention has been drawn to the minor cannabinoid, lawmakers are making moves necessary to ban it.
CBD oil is derived from a hemp plant, which is usually abundantly found in countries like Central China and several parts across Mediterranean Europe. CBD (or cannabidiol) is a health-promoting substance commonly present in the hemp plant, and it’s the main active ingredient in the CBD oil products. Their Origins.
There are numerous companies providing ancillary services to the industry, as well as many derivative plays, like pharma and biotech companies making cannabinoid-based drugs and service/product providers that used to operate outside the marijuana industry but have gotten on board since legalization. The over-the-counter issue.
Despite the similarities between these two cannabinoids, they don’t each provide a truly identical response. Both of these cannabinoids possess a chain of carbon atoms — however, delta-9 THC has its double bond on the ninth carbon atom, while delta-8 has its own double bond on the eighth carbon atom.
The Canna Law Blog has been writing about the Drug Enforcement Agency’s (DEA) interim final rule (IFR) on hemp since its August publication in the Federal Register: Watch Out! The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. So will the DEA start raiding hemp processors?
The Drug Enforcement Administration (DEA) issued an interim final rule on hemp (“DEAhemp rule” or “rule”) on August 20, 2020. Yet, as we warned in 2020, the rule creates perils for the hemp derivative industry. Challenging the DEAhemp rule. percent on a dry weight basis.
On August 20, 2020, the Drug Enforcement Administration (DEA) issued an interim rule on hemp, hemp-derived CBD (Hemp CBD) and other hemp-derived cannabinoids. If you’re in the hemp derivative business, trust the DEA at your own peril. with a delta-9 THC concentration of not more than 0.3
The Drug Enforcement Administration (DEA) issued an interim final rule on hemp (“DEAhemp rule” or “rule”) on August 20, 2020. Yet, as we warned in 2020, the rule creates perils for the hemp derivative industry. Challenging the DEAhemp rule. percent on a dry weight basis.
The hemp industry is not the only one that’s pushing back against the Drug Enforcement Administration (DEA)’s hemp Interim Final Rule (the “ Rule ”). If you read this blog, you’ll recall the hemp industry sued the DEA following the release of its Rule in August 2020. billion in 2019.
And then you scroll a little further down and discover that the new Farm Bill is going to legalize hemp farming in the United States for the first time in eighty years ( huzzah!). RELATED STORY. The Top 10 Cannabis Stories of 2018. Or that Big Tobacco just invested $2.4 billion dollars in the weed business ( f**k!).
Until a few weeks ago, everyone in the hemp world thought the next big development would come from the federal Food and Drug Administration (after all, the FDA recently submitted proposed guidance to the White House, which has yet to be released). The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids.
On Friday, the Drug Enforcement Administration (“DEA”) released an Interim Final Rule (the “ Rule ”) that, as we discussed , threatens the hemp industry by treating partially processed hemp extract not intended for consumption (also known as “intermediary hemp”) as a Schedule I controlled substance.
The Drug Enforcement Administration (DEA) seems happy to respond to public and private parties inquiring about the control status of various substances. DEA answers some of these inquiries more quickly than others, and the response letters are usually short and to the point. What are the legal ramifications of DEA writing these things?”
On August 21, the Drug Enforcement Agency (the “DEA”) released an Interim Final Rule (the “ Rule ”), which, in part, suggests that in-process hemp extract shall be treated as a schedule I controlled substance during any point at which its THC concentration exceeds 0.3 percent on a dry weight basis.
The Drug Enforcement Administration (DEA) seems happy to respond to public and private parties inquiring about the control status of various substances. DEA answers some of these inquiries more quickly than others, and the response letters are usually short and to the point. What are the legal ramifications of DEA writing these things?”
Neither the Senate bill nor the House bill would preempt state or Indian law regarding hemp or the regulation of hemp products. This means states and tribes will retain a lot of latitude in regulating hemp and hemp-derived products– which gets people fired up. See: What Happened to Hemp? (“ What Happened ”).
For years, people have tried to decipher the incredibly poorly worded (I can’t stress this enough) language in the 2018 Farm Bill and what it means for intoxicating hemp products like THCA products or delta-8. In the last week or so, there’s been a lot of bad news for the intoxicating hemp products industry.
The hemp industry is not the only one that’s pushing back against the Drug Enforcement Administration (DEA)’s hemp Interim Final Rule (the “ Rule ”). If you read this blog, you’ll recall the hemp industry sued the DEA following the release of its Rule in August 2020. billion in 2019.
When Congress passed the 2018 Farm Bill, did it intend to legalize intoxicating hemp products? And why didn’t it address the manufacture or sale of intoxicating hemp products? ” Congress did not intend to open Pandora’s Box to any form of legal intoxicating hemp product. That in my view, is wrong. delta-9 THC.
He said: “licensed acres in hemp are at pre-farm bill levels.” Before the 2018 Farm Bill, only a few states ran limited “research” pilot programs for hemp. But, take a look: The USDA 2022 National Hemp Report , at page 1, indicates that all industrial hemp “in the open” totaled 28,314 acres. Could that be true?
Everyone in the hemp industry knows that last fall the U.S. Department of Agriculture (“USDA”) released its interim hemp rules governing the production of hemp. Why the USDA Testing Rules Will Hurt the Hemp Industry. Hemp-CBD Across State Lines: Special Update on USDA Hemp Rules. Hemp breeding and research.
A couple of weeks ago I wrote about the USDA’s decision to reopen commenting on the interim hemp rule for 30 days. Here is a good article by Hemp Grower magazine on the reopening). The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. The deadline for submitting comments is October 8.
When the 2018 Farm Bill was inked, one of the biggest perceived wins was a provision prohibiting states from interfering with interstate transport or shipment of hemp. Many hemp transporters today face just as much risk when transporting hemp as they did before the 2018 Farm Bill was signed—and in some cases, even more risk.
Import and Export of Marijuana, Hemp and Paraphernalia”, the replay video is just above. In particular, there’s a renewed demand internationally for hemp and hemp-derived products. Of course, in all countries, only specific types of cannabis products are going to be lawful: generally, hemp and hemp derivatives.
Ever since Congress passed the Agricultural Improvements Act of 2018 (or 2018 Farm Bill ), people have tried to find creative ways to sell intoxicating hemp-derived products. A primer on the 2018 Farm Bill and THCA For starters, Hemp may only have 0.3% The issue is that hemp also generally delta-9 tetrahydrocannabinol acid (THCA).
Most interestingly, the reconstituted SB 353 would allow OLCC licensees to export intoxicating products that fall under the federal definition of hemp, along with marijuana seeds. All very interesting stuff, especially coming from the first state to ban the sale of artificially derived cannabinoids (with limited exceptions).
Marijuana genetics: are they hemp or marijuana? In short, under federal law, marijuana genetics appear to be hemp. However, they are neither strictly hemp nor marijuana until a state makes that determination. In fact, in some states they may be both marijuana and hemp. Hemp is defined as the plant Cannabis sativa L.
We got 51 hemp-derived Delta-8 THC products tested by an independent lab, and found high levels of Delta-9 THC in most of them. And finally, will you be getting any residues from the manufacturing process alongside your cannabinoids? That’s more than just oops! Oracle wrote 21 October 2021. And that was just the beginning.
On October 27, the New York Department of Health (the “ DOH ”) released much anticipated proposed rules to regulate the processing, manufacturing, sale and marketing of cannabinoidhemp products in the state (the “ Rules ”). The Rules contain key terms and definitions that are rarely found in hemp state regulations.
When Congress passed the 2018 Farm Bill, did it intend to legalize intoxicating hemp products? And why didn’t it address the manufacture or sale of intoxicating hemp products? ” Congress did not intend to open Pandora’s Box to any form of legal intoxicating hemp product. That in my view, is wrong. delta-9 THC.
FDA and DEA in describing its reasoning for this position. FDA and DEA. Filipino legislators and regulators are both aware of the nuances in cannabis as hemp, cannabis as marijuana, and cannabinoids derived from cannabis. As China’s Hemp Industry Suffers, U.S. Hemp Growers Prepare to Pounce.
As research on the different cannabinoids and terpenes – and other compounds produced by the cannabis plant – advances, more and more testimonies claim that the efficacy of these substances is beyond doubt. CBD oils and extracts are made from organic hemp crops. Benefits of CBD for pets.
And if it is derived from hemp, it is not independently scheduled – at least if you read the Controlled Substances Act and 2018 Farm Bill literally. But, there’s a huge controversy about whether it can be controlled, with agencies like the DEA saying it is. Delta-8, however, is not an approved drug ingredient.
As anticipated, Delta-8 tetrahydrocannabinol (“Delta-8 THC”) has become the hottest, most flourishing cannabinoid currently found on the U.S. In the past few months, the sales of Delta-8 THC products have exploded, representing the fastest growing segment of hemp-derived products. Delta-8 THC Products.
International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.
the current and future treatment of emerging cannabinoids beyond CBD such as CBG , CBN , and synthetic CBD. the current and future treatment of emerging cannabinoids beyond CBD such as CBG , CBN , and synthetic CBD. Hemp CBD Across Europe: Spain. Should You Import Hemp to the United States? Distressed U.S.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content